EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TERT promoter mutations and recurrence patterns in differentiated thyroid carcinoma

Hyun Jin Ryu, Ji Hyun Yoo, Da Eun Leem, Chang-Seok Ki, Jung Hee Shin, Young Lyun Oh, Jung-Han Kim, Ji Eun Jun, Kyu Jeung Ahn, Joonghyun Ahn, Sun Wook Kim, Jae Hoon Chung und 2 weitere

Endocrine-Related Cancer · 2026

DOI: 10.1530/erc-25-0273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2026. Verfasst von Hyun Jin Ryu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine, Kyung Hee University Hospital at …. Hauptthemen laut MEDLINE: Telomerase, Thyroid Neoplasms, Neoplasm Recurrence, Local, Promoter Regions, Genetic. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Telomerase reverse transcriptase promoter mutations ( TERT ) are known prognostic factors associated with poor outcomes in differentiated thyroid carcinoma (DTC). We analyzed differences in DTC recurrence patterns over time according to TERT . A retrospective review was conducted on DTC patients who achieved remission after total thyroidectomy and/or radioactive iodine treatment at Samsung Medical Center between 1994 and 2004. The sites and patterns by time of recurrence in the patients were reviewed. In total, 367 patients with a median follow-up of 14 years (interquartile range, 12–17 years) were included. Recurrence occurred in 91 patients, wherein 56 had lymph node recurrence and 35 had either local or distant recurrence. TE RT and tumor size

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseThyroid NeoplasmsNeoplasm Recurrence, LocalPromoter Regions, GeneticMutationHumansFemaleMaleMiddle AgedRetrospective StudiesAdultPrognosisThyroidectomy

Stichwörter der Autor:innen

TERT promoter mutationsdifferentiated thyroid carcinomaprognosisrecurrence

Substanzen

TelomeraseTERT protein, human

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea.
  • Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea.
  • Green Cross Genome, Yongin, Korea.
  • Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ORCID-Profile: Tae Hyuk Kim, Young Ik Son

Zitieren

APA

Ryu, H. J., Yoo, J. H., Leem, D. E., Ki, C. S., Shin, J. H., Oh, Y. L., Kim, J. H., Jun, J. E., Ahn, K. J., Ahn, J., Kim, S. W., Chung, J. H., Kim, T. H., & Son, Y. I. (2026). TERT promoter mutations and recurrence patterns in differentiated thyroid carcinoma. Endocrine-Related Cancer. https://doi.org/10.1530/erc-25-0273

Vancouver

Ryu HJ, Yoo JH, Leem DE, Ki CS, Shin JH, Oh YL, et al. TERT promoter mutations and recurrence patterns in differentiated thyroid carcinoma. Endocrine-Related Cancer. 2026. doi:10.1530/erc-25-0273

BibTeX
@article{Ryu2026,
  author = {Ryu, Hyun Jin and Yoo, Ji Hyun and Leem, Da Eun and Ki, Chang-Seok and Shin, Jung Hee and Oh, Young Lyun and Kim, Jung-Han and Jun, Ji Eun and Ahn, Kyu Jeung and Ahn, Joonghyun and Kim, Sun Wook and Chung, Jae Hoon and Kim, Tae Hyuk and Son, Young Ik},
  title = {TERT promoter mutations and recurrence patterns in differentiated thyroid carcinoma},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  doi = {10.1530/erc-25-0273}
}
Kostenlos starten →